Purchase Order 75N94024P00093
- Not listed
- The National Institute of Child Health and Human Development (NICHD) awarded a $25,496 firm fixed-price purchase order to Quanterix Corporation for laboratory equipment maintenance services on an SR-X Biomarker Detection System. The contract, issued on January 14, 2026, is severable in nature and extends through January 13, 2028. Work will be performed at Quanterix's facility in Billerica, Massachusetts. This award carries no small business or other set-aside designation, reflecting the...
- This is a $84,013.00 firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Quanterix Corporation. The contract is for the development of custom assays, including reagents, for use on Quanterix's Simoa (single molecule array) instruments. This work supports NICHD's biomedical research programs. The contract was awarded without a set-aside designation,...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Quanterix Corporation for the supply of Neurology 4-Plex A Advantage Kits, SR-X Disc Kits, and Wash Buffers, with a total value of $30,152.63. The award has a completion date of July 31, 2024. Quanterix is a life sciences company that specializes in ultra-sensitive digital biomarker detection technology, and has provided various products and services...
- This federal contract award, valued at $14,525.80, was issued by the National Institute of Child Health and Human Development (NICHD) to Quanterix Corporation, a life sciences company that specializes in ultra-sensitive digital biomarker detection technology. The contract, titled "NICHD - INFLIGHT V2 ADVANTAGE KIT", is a firm-fixed-price purchase order with a completion date of September 30, 2024. Quanterix has also been awarded an indefinite delivery contract (IDV) by the Department...
- The National Institute of Child Health and Human Development (NICHD), a component of the Department of Health and Human Services' National Institutes of Health (NIH), has awarded a $11,041 purchase order to Quanterix Corporation of Billerica, Massachusetts. Under this firm fixed price contract running from August 2023 through August 2024, Quanterix will provide NICHD with supplies necessary for neurology testing, specifically a 2-plex biomarker assay kit to detect glial fibrillary acidic protein...
- Quanterix Corporation has been awarded a firm fixed price purchase order by the National Institutes of Health National Institute on Aging totaling $12,800.88. The contract has no set-aside designation. Under this award, Quanterix will provide its single molecule array platform and associated assay kits and reagents to support the agency's biomarker detection research efforts. Additionally, Quanterix holds an indefinite delivery contract from the Department of Veterans Affairs Veterans Health...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract, valued at $100,500.00, is for custom assay development services. Quanterix has received over $30 million in prior federal contracts from agencies including the National Institutes of Health,...
- This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
- The contract award to Quanterix Corporation, a life sciences company specializing in digital biomarker detection technology, was issued by the National Institute on Drug Abuse, part of the National Institutes of Health. The $151,775.25 firm-fixed-price purchase order is for the provision of advanced instruments, assay kits, and research services to support biomedical research and diagnostic development. This contract is not designated as a set-aside. Quanterix has also been awarded an indefinite...
- This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
Quanterix Corporation has been awarded an $11,845 purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide a one-year service agreement for biomarker detection and microplate washer equipment. The contract calls for Quanterix to deliver biomarker detection and microplate washing services in support of NICHD's research programs. Performance will take place in Bethesda, Maryland over the one-year period beginning January 14, 2024 and ending January 13, 2025. The contract utilizes a firm fixed price structure. No subcontractors or set-aside designations were indicated. This award furthers NICHD's mission to ensure that every child can live to their full potential and grow up healthy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 12/21/23 |